Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer - Concepedia

Concepedia

Publication | Open Access

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

DOI Full Paper Access

28

Citations

37

References

2022

Year

Jacob P. van Vloten, Kathy Matuszewska, Mark A.A. Minow, Jessica A. Minott, Lisa A. Santry, Madison Pereira, Ashley A. Stegelmeier, Thomas M. McAusland, Elaine M. Klafuric, Khalil Karimi,

Journal for ImmunoTherapy of Cancer

Abstract

The data herein support the translational potential of OrfV as an NK stimulating immunotherapeutic for the treatment of advanced-stage ovarian cancer.

References

	Year	Citations

Page 1